Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.
作者： Raquel Maia , Flavia Vasconcelos , Paloma Souza , Vivian Rumjanek
DOI: 10.3390/MOLECULES23010119
关键词:
摘要: … Chronic myeloid leukemia (CML) is a form of hematopoietic … by the fusion of BCR and ABL genes and results in a constitutively active … These three variants are reported to be in linkage …
mdpi.com
core.ac.uk
sci-hub.se 参考文章(145)
Mansoor N. Saleh, Sally Haislip, Joyce Sharpe, Tamara Hess, James Gilmore, James Jackson, Kavita R. Sail, Solveig G. Ericson, Lei Chen, Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting. Current Medical Research and Opinion. ,vol. 30, pp. 529- 536 ,(2014) , 10.1185/03007995.2013.858621
Fernanda de Faria, Maria Bento Leal, Paula Bernardo, Paulo Costa, Raquel Maia, NFκB pathway and microRNA-9 and -21 are involved in sensitivity to the pterocarpanquinone LQB-118 in different CML cell lines. Anti-cancer Agents in Medicinal Chemistry. ,vol. 15, pp. 345- 352 ,(2015) , 10.2174/18715206113139990108
T. P. Stromskaya, E. Yu. Rybalkina, S. S. Kruglov, T. N. Zabotina, E. B. Mechetner, A. G. Turkina, A. A. Stavrovskaya, Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib Biochemistry. ,vol. 73, pp. 29- 37 ,(2008) , 10.1134/S0006297908010045
Hemant Malhotra, Pratibha Sharma, Bharti Malhotra, Shipra Bhargava, Sandeep Jasuja, Madhu Kumar, Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase. Indian Journal of Medical Research. ,vol. 142, pp. 175- 182 ,(2015) , 10.4103/0971-5916.164250
Marius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer, Susan E. Bates, Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib Drug Metabolism and Disposition. ,vol. 38, pp. 1371- 1380 ,(2010) , 10.1124/DMD.109.031302
Amie S. Corbin, Anupriya Agarwal, Marc Loriaux, Jorge Cortes, Michael W. Deininger, Brian J. Druker, Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity Journal of Clinical Investigation. ,vol. 121, pp. 396- 409 ,(2011) , 10.1172/JCI35721
Jacob Vine, Sara Bar Cohen, Rosa Ruchlemer, Neta Goldschmidt, Moshe Levin, Diana Libster, Alexander Gural, Moshe E. Gatt, David Lavie, Dina Ben-Yehuda, Deborah Rund, Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Leukemia & Lymphoma. ,vol. 55, pp. 2525- 2531 ,(2014) , 10.3109/10428194.2014.893307
Flavia C. Vasconcelos, Karina L. Silva, Paloma Silva de Souza, Luiz Felipe R. Silva, Arthur Moellmann-Coelho, Claudete E. Klumb, Raquel Ciuvalschi Maia, Variation of MDR Proteins Expression and Activity Levels According to Clinical Status and Evolution of CML Patients Cytometry Part B-clinical Cytometry. ,vol. 80, pp. 158- 166 ,(2011) , 10.1002/CYTO.B.20580
Jane F Apperley, Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia Lancet Oncology. ,vol. 8, pp. 1018- 1029 ,(2007) , 10.1016/S1470-2045(07)70342-X
Markus Stenner, Antje Weinell, Tobias Ponert, Aline Hardt, Moritz Hahn, Simon F Preuss, Orlando Guntinas-Lichius, Jens Peter Klussmann, Cytoplasmic expression of survivin is an independent predictor of poor prognosis in patients with salivary gland cancer Histopathology. ,vol. 57, pp. 699- 706 ,(2010) , 10.1111/J.1365-2559.2010.03693.X